Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Foletta Insider Profile
4 Followers
Mark Foletta, Interim CFO at Biocept, holds 0.00 shares in Biocept (Ticker: BIOCQ), holds 15.04K shares in Forte Biosciences (Ticker: FBRX), holds ― shares in Enanta Pharmaceuticals (Ticker: ENTA). Most recently, Mark Foletta ― shares of Biocept on ― for an estimated value of ―.
Profitable Transactions
1 out of 9 Profitable Transactions
Average Return
-38.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Foletta holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Foletta
Mark Foletta's Trading History
Biocept
―
Interim CFO
―
$0.00
Forte Biosciences
May 29, 2019
EVP & CFO
Uninformative Buy
21.45K
$240.67K
Enanta Pharmaceuticals
―
Director
―
―
Dexcom
Jun 20, 2024
Director
Uninformative Sell
702.00K
$4.32M
Regulus
Dec 06, 2017
Director
Uninformative Buy
64.00K
$120.41K
AMN Healthcare Services
Apr 23, 2024
Director
Uninformative Buy
95.73K
$264.96K
Ambit
―
―
―
―
List of latest transactions for each holding click on a transaction to see Mark Foletta's performance on stock
You May Also Like
Mark Foletta insider profile FAQ
What is the percentage of profitable transactions made by Mark Foletta?
The percentage of profitable transactions made by Mark Foletta is 11%.
What is the average return per transaction made by Mark Foletta?
The average return per transaction made by Mark Foletta is -38.60%.
What stocks does Mark Foletta hold?
Mark Foletta holds: BIOCQ, FBRX, ENTA, DXCM, RGLS, AMN, ~AMBI stocks.
What was Mark Foletta’s latest transaction?
Mark Foletta latest transaction was an Uninformative Buy of ―.
What was Mark Foletta's most profitable transaction?
Mark Foletta’s most profitable transaction was an Informative Sell of DXCM stock on September 9, 2016. The return on the trade was 23.30%.
What is Mark Foletta's role in Biocept?
Mark Foletta's role in Biocept is Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.